Skip to main content

Table 1 Oncogenic HPV genotypes present in CIN3 + plus study biopsiesa

From: Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study

  Retrospective (2014) Prospective (2015) All p-value
Biopsies, n = 465 Biopsies, n = 303 N = 768
HPV types, n, % (95% CI) HPV types, n, % (95% CI)
HPV 16 and/ or 18 281, 60.4 (55.8–64.9) 194, 64.0 (58.3–69.4) 475, 61.8 (58.3–65.3) 0.316
Oncogenic HPV genotypes in nonavalent vaccineb 417, 89.7 (86.5–92.3) 270, 89.1 (85.0–92.4) 687, 89.5 (87.1–91.5) 0.802
All other high-risk HPV genotypesc 45, 9.7 (7.1–12.7) 21, 6.9 (4.3–10.4) 66, 8.6 (6.7–10.8) 0.184
  1. Abbreviations: CI confidence interval
  2. aMultiple HPV genotypes may be present in one biopsy so the total number of HPV types is higher than the number of biopsies
  3. bOne more of the following HPV genotypes present: 16, 18, 31, 33, 45, 52, 58
  4. cOne or more of the following HPV genotypes present: 35, 39, 51, 56, 59